Ticker
AEGIR.ST

Price
6.75
Stock movement down
-1.35 (-16.72%)
Company name
Aegirbio AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
143.58M
Ent value
149.04M
Price/Sales
10.78
Price/Book
0.40
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-97.46%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

AEGIR.ST does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales10.78
Price to Book0.40
EV to Sales11.19

FINANCIALS

Per share

Loading...
Per share data
Current share count21.28M
EPS (TTM)-5.02
FCF per share (TTM)-5.95

Income statement

Loading...
Income statement data
Revenue (TTM)13.32M
Gross profit (TTM)6.06M
Operating income (TTM)-83.90M
Net income (TTM)-94.74M
EPS (TTM)-5.02
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)45.50%
Operating margin (TTM)-629.83%
Profit margin (TTM)-711.23%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash21.99M
Net receivables4.39M
Total current assets50.59M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets385.08M
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities11.76M
Total liabilities27.45M
Shareholder's equity357.63M
Net tangible assets26.36M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-109.66M
Capital expenditures (TTM)2.73M
Free cash flow (TTM)-112.39M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-26.49%
Return on Assets-24.60%
Return on Invested Capital-26.49%
Cash Return on Invested Capital-31.43%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open7.60
Daily high7.60
Daily low6.40
Daily Volume1.58M
All-time high365.17
1y analyst estimate-
Beta4.78
EPS (TTM)-5.02
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
AEGIR.STS&P500
Current price drop from All-time high-98.15%-12.18%
Highest price drop-98.15%-56.47%
Date of highest drop25 Aug 20229 Mar 2009
Avg drop from high-52.34%-11.38%
Avg time to new high18 days12 days
Max time to new high275 days1805 days
COMPANY DETAILS
AEGIR.ST (Aegirbio AB) company logo
Marketcap
143.58M
Marketcap category
Small-cap
Description
AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was incorporated in 2019 and is based in Lund, Sweden.
Employees
17
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found